Prevalence and Risk Factors of Oropharyngeal Dysphagia in Newly Diagnosed Head-and-Neck Cancer Patients.

Bibliographic Details
Title: Prevalence and Risk Factors of Oropharyngeal Dysphagia in Newly Diagnosed Head-and-Neck Cancer Patients.
Authors: Florie, Michelle G. M. H.1,2 (AUTHOR) michelle.florie@mumc.nl, Wieland, Monse W. M.1,2 (AUTHOR), Pilz, Walmari1,2 (AUTHOR), Partoens, Rosanne1,2,3 (AUTHOR), Winkens, Bjorn4,5 (AUTHOR), Hoeben, Ann6 (AUTHOR), Rommel, Nathalie3,7 (AUTHOR), Baijens, Laura W. J.1,2 (AUTHOR)
Source: Cancers. Jan2025, Vol. 17 Issue 1, p9. 16p.
Subject Terms: *HEAD & neck cancer diagnosis, *HEAD & neck cancer treatment, *RISK assessment, *MALNUTRITION, *RESEARCH funding, *HEAD & neck cancer, *NUTRITIONAL assessment, *LOGISTIC regression analysis, *QUESTIONNAIRES, *EARLY detection of cancer, *DISEASE prevalence, *DESCRIPTIVE statistics, *LONGITUDINAL method, *TUMOR classification, *DEGLUTITION disorders, *COMORBIDITY, *DISEASE risk factors
Geographic Terms: NETHERLANDS
Abstract: Simple Summary: To our knowledge, no studies have been published on systematic screening for oropharyngeal dysphagia (OD) in all newly diagnosed head-and-neck cancer (HNC) patients irrespective of cancer stage and primary tumor location. This knowledge gap has led to uncertainty regarding the prevalence of OD within this population. Moreover, the prevalence of OD and its relationship with demographic and oncological characteristics can guide us to more effective screening and management of a patient's risk profile before the start of cancer treatment. This study unveiled that approximately one-fifth of all newly diagnosed HNC patients are at risk of OD before the start of cancer treatment, with advanced-stage cancer and malnutrition emerging as significant risk factors. These findings equip health professionals to prioritize closer monitoring and tailored interventions to prepare patients with a risk of OD and OD-related complications for their entire cancer treatment trajectory. Background: Head-and-neck cancer (HNC) can cause oropharyngeal dysphagia (OD). Early identification of OD in newly diagnosed HNC patients is important to better prepare patients for their cancer treatment trajectory. The aim of this study is (1) to assess the prevalence of OD in HNC patients within three weeks before the start of cancer treatment and (2) to investigate which demographic and oncological characteristics may be risk factors associated with the risk of OD at baseline. Methods: Patients (N = 225) completed the Eating Assessment Tool-10 (EAT-10) and Short Nutritional Assessment Questionnaire (SNAQ). Logistic regression analysis was conducted to examine the association between OD versus demographic and oncological characteristics. Results: A total of 21.3% (proportion 0.213; 95% CI 0.163–0.274) of the patients were at risk for OD. After correction for age, Charlson Comorbidity Index (CCI) grade, and primary tumor location, a significant association was found between advanced-stage cancer versus the risk of OD. Additionally, post hoc analysis revealed a significant association between the risk of malnutrition versus the risk of OD. Conclusions: Approximately one-fifth of all newly diagnosed HNC patients are at risk of OD, with advanced-stage cancer and malnutrition emerging as significant risk factors of OD. These findings empower health professionals toward more effective screening and management of a patient's risk profile before the start of HNC treatment. [ABSTRACT FROM AUTHOR]
Copyright of Cancers is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
More Details
ISSN:20726694
DOI:10.3390/cancers17010009
Published in:Cancers
Language:English